Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.

Daws LC.

Pharmacol Ther. 2009 Jan;121(1):89-99. doi: 10.1016/j.pharmthera.2008.10.004. Epub 2008 Oct 29. Review.

2.

Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.

Ribeiro P, Patocka N.

Parasitol Int. 2013 Dec;62(6):629-38. doi: 10.1016/j.parint.2013.06.003. Epub 2013 Jun 22. Review.

PMID:
23800409
3.

Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.

Duan H, Wang J.

J Pharmacol Exp Ther. 2010 Dec;335(3):743-53. doi: 10.1124/jpet.110.170142. Epub 2010 Sep 21.

4.

Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Horton RE, Apple DM, Owens WA, Baganz NL, Cano S, Mitchell NC, Vitela M, Gould GG, Koek W, Daws LC.

J Neurosci. 2013 Jun 19;33(25):10534-43. doi: 10.1523/JNEUROSCI.5687-11.2013.

5.

Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.

Dutta AK, Santra S, Sharma H, Voshavar C, Xu L, Mabrouk O, Antonio T, Reith ME.

PLoS One. 2014 Nov 26;9(11):e113420. doi: 10.1371/journal.pone.0113420. eCollection 2014.

6.

Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.

Fraser-Spears R, Krause-Heuer AM, Basiouny M, Mayer FP, Manishimwe R, Wyatt NA, Dobrowolski JC, Roberts MP, Greguric I, Kumar N, Koek W, Sitte HH, Callaghan PD, Fraser BH, Daws LC.

Eur J Pharmacol. 2019 Jan 5;842:351-364. doi: 10.1016/j.ejphar.2018.10.028. Epub 2018 Oct 25.

PMID:
30473490
7.

Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.

Zhou M, Duan H, Engel K, Xia L, Wang J.

Drug Metab Dispos. 2010 Oct;38(10):1798-805. doi: 10.1124/dmd.110.032987. Epub 2010 Jun 30.

8.

Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.

Andersen J, Kristensen AS, Bang-Andersen B, Strømgaard K.

Chem Commun (Camb). 2009 Jul 7;(25):3677-92. doi: 10.1039/b903035m. Epub 2009 May 7. Review.

PMID:
19557250
9.

Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?

Goulet M, Miller GM, Bendor J, Liu S, Meltzer PC, Madras BK.

Synapse. 2001 Dec 1;42(3):129-40.

PMID:
11746710
10.

Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.

Haenisch B, Bönisch H.

Pharmacol Ther. 2011 Mar;129(3):352-68. doi: 10.1016/j.pharmthera.2010.12.002. Epub 2010 Dec 13. Review.

PMID:
21147164
11.

Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action.

Wang K, Sun S, Li L, Tu M, Jiang H.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 4;53:90-8. doi: 10.1016/j.pnpbp.2014.03.005. Epub 2014 Mar 20.

PMID:
24657329
12.

Revisiting serotonin reuptake inhibitors and the therapeutic potential of "uptake-2" in psychiatric disorders.

Daws LC, Koek W, Mitchell NC.

ACS Chem Neurosci. 2013 Jan 16;4(1):16-21. doi: 10.1021/cn3001872.

13.

Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.

Han TK, Proctor WR, Costales CL, Cai H, Everett RS, Thakker DR.

J Pharmacol Exp Ther. 2015 Mar;352(3):519-28. doi: 10.1124/jpet.114.220350. Epub 2015 Jan 6.

14.

Cardiovascular afferents cause the release of 5-HT in the nucleus tractus solitarii; this release is regulated by the low- (PMAT) not the high-affinity transporter (SERT).

Hosford PS, Millar J, Ramage AG.

J Physiol. 2015 Apr 1;593(7):1715-29. doi: 10.1113/jphysiol.2014.285312. Epub 2015 Feb 19.

15.

Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma-derived cell line.

Naganuma F, Yoshikawa T, Nakamura T, Iida T, Harada R, Mohsen AS, Miura Y, Yanai K.

J Neurochem. 2014 May;129(4):591-601. doi: 10.1111/jnc.12665. Epub 2014 Feb 13.

16.

Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.

Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S.

Mol Psychiatry. 2012 Sep;17(9):926-39. doi: 10.1038/mp.2011.87. Epub 2011 Jul 19.

17.

Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.

Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK.

JAMA. 2006 Oct 4;296(13):1609-18.

PMID:
17018806
18.

A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.

Fox MA, Andrews AM, Wendland JR, Lesch KP, Holmes A, Murphy DL.

Psychopharmacology (Berl). 2007 Dec;195(2):147-66. Epub 2007 Aug 22. Review.

PMID:
17712549
19.
20.

Supplemental Content

Support Center